ClinicalTrials.Veeva

Menu

Exercise in Critically Ill Patients With Sepsis

The University of Queensland logo

The University of Queensland

Status

Unknown

Conditions

Sepsis Syndromes

Treatments

Other: Usual practice
Other: Exercise

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study will investigate whether early exercise in critically ill patients will decrease inflammatory markers, increase pro-inflammatory markers and prevent loss of muscle mass.

Full description

This study will investigate the effects of an early targeted rehabilitation program on inflammatory markers and muscle mass in patients with sepsis syndromes in intensive care.

The Primary Hypothesis is that an early targeted rehabilitation ICU patients with sepsis syndromes over 7 days will Prevent loss of lean muscle mass by within 7 days of recruitment to the study. Decrease pro-inflammatory and increase anti-inflammatory cytokines within 7 days of recruitment to the study.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Systemic inflammatory response syndrome with a proven or suspected infectious etiology.
  • 18 years and over
  • Relatives willing to give consent
  • Admitted to intensive care and likely to remain ventilated for > 48 hours

Exclusion criteria

  • Patients with septic shock unresponsive to maximal treatment or who are moribund or have an expected mortality within 48 hours
  • Head injuries
  • Burn injury
  • Multiple lower limb fractures

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups, including a placebo group

Control (usual practice)
Placebo Comparator group
Treatment:
Other: Usual practice
Exercise
Experimental group
Treatment:
Other: Exercise

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems